concentration is a good marker for the follow-up of this disease. The source of CA125 synthesis is still debated. Endometrial, CA125 is immunolocalized in the amnion and derivatives peritoneal, ovarian and amniotic cells have been demonof fetal coelomic epithelia, decidua and placenta (Kabawat strated to produce and secrete CA125. Different studies et al., 1983) . In adult tissues it is found in the female genital show that the peritoneum is a source of CA125. The present tract epithelium except on the surface of the ovary (Kabawat study aimed at investigating in vivo and in vitro de Bruijn et al., 1986) . The epithelium of the peritoneal contribution to circulating CA125. Cultures of pancreas, colon, gall bladder, stomach, lung, kidney, breast uterine peritoneum, abdominal peritoneum and myome- (Dietel et al., 1986; Nouwen et al., 1987) , and endometriotic trium explants were performed and CA125 measured in lesions is also positive for CA125 (Fedele et al., 1988) . Many the culture medium. To modulate the potential production body fluids such as milk, amniotic fluid, peritoneal or pleural of CA125, the explants were cultured with or without fluid, cervical mucus and seminal fluid contain CA125 (de cycloheximide, bacterial lipopolysaccharide (LPS) or ascitic Bruijn et al., 1986; O'Brien et al., 1986; Bergmann et al. , fluid. In a prospective study, we compared a group of 1987; Jacobs et al., 1988; Schwartz et al., 1989; Meisser et al. , patients after abdominal surgery (n ⍧ 19; nine men, 10 1996). Four sites of CA125 synthesis have been studied so women) with a group after extra-abdominal surgery (n ⍧ far. Endometrial, decidual, amniotic and peritoneal cells have 21; 11 men, 10 women), in order to detect a postoperative been shown to produce CA125 in vitro (Bischof et al., 1986 ; increase of serum CA125. De-novo synthesis of CA125 Barbati et al., 1990; Weintraub et al., 1990; , could not be demonstrated in the cultures of uterine and 1997, 1998) . The normal ovary does not seem to be an abdominal peritoneum and in myometrium, but CA125 important source of CA125 production, since after ovarian concentrations were detectable in the culture medium stimulation CA125 concentrations do not increase and there without being modulated by cycloheximide, LPS or ascitic is no CA125 concentration gradient from the ovaries to the fluid. After peritoneal surgery, the proportion of patients peripheral circulation (Bischof, unpublished data) . However, with increased serum CA125 was significantly higher primary cultures of human ovarian surface epithelial cells (P < 0.03) after abdominal surgery as compared with extrasecrete detectable but modest concentrations of CA125 (Zeimet abdominal surgery. This is considered as indirect evidence et al., 1998) . Different studies suggest that the peritoneum is for in-vivo production of CA125 by the peritoneum.
an important source of CA125. The antigen can be detected Key words: CA125/cell culture/myometrium/ovarian cancer/ immunohistochemically in the mesothelial cells of peritoneum, peritoneum pleura and pericardium (Kabawat et al., 1983) . Two studies (Zeillemaker et al., 1994; Zeimet et al., 1998) demonstrated CA125 secretion by monolayers of mesothelial cells in culture.
The role of peritoneal inflammation in the increase of the Introduction marker is also suggested by pathological conditions such as ruptured ectopic pregnancy (Bischof et al., 1989) , pelvic Cancer antigen 125 (CA125) is an antigenic determinant recognized by a murine monoclonal antibody OC125 (Bast inflammatory disease and endometriosis (Johansson et al., 1998) . Direct in-vitro evidence demonstrating the effects of et al., 1981) . It has been used as a tumour marker for ovarian cancer since the description of high concentrations of CA125 inflammatory cytokines such as interleukin-1β (IL-1β) or tumour necrosis factor-α (TNF-α) on human peritoneal cells in 80% of patients with epithelial ovarian cancer . However, this elevation is not specific and has also been is controversial (Zeillemaker et al., 1994; Zeimet et al., 1998) . Furthermore, elevated CA125 concentrations have been found observed in many physiological and pathological conditions: during menses (Lehtovirta et al., 1990; Bon et al., 1999) , after abdominal surgery: Redman et al. (Redman et al., 1988) observed an elevation in peritoneal fluid but not in the sera, endometriosis ( Barbieri et al., 1986; Pittaway and Fayez, 1987; Talbot et al. (Talbot et al., 1989) found a postoperative CA125 increase after laparotomy in the sera of patients with normal preoperative concentration, while a third study (Yedema et al., 1993) showed a significant CA125 increase in the serum after laparotomy for benign diseases and non-ovarian malignancies.
The purpose of the present study was to investigate in vivo and in vitro if the peritoneum is a source of CA125 and if it contributes to circulating CA125. In practical terms, we wanted to see if the increase in CA125 was higher after a peritoneal surgery and if the proportion of patients having an increased CA125 concentration was higher in patients having undergone a peritoneal surgery compared with non-peritoneal surgery. 
Materials and methods
were cultured in complete RPMI (see Materials and methods).
Tissue cultures
Explants were also cultured in RPMI supplemented with 10 µg/ml cycloheximide (n ϭ 12) with 30% v/v ascitic fluid (n ϭ 9) and Uterine peritoneum and myometrium were obtained from patients with 100 µg/ml lipopolysaccharides (LPS; n ϭ 4). undergoing hysterectomy for reasons other than malignancy. Abdominal peritoneum was obtained from women undergoing elective laparotomy.
ively and 48 h postoperatively from each patient. After centrifugation After removal, the tissue pieces were minced with scissors, washed (10 min at 1500 g), plasma samples were stored at -20°C until and placed in HBSS (Hanks' balanced salt solution, Sigma, St Louis, assayed. CA125 concentration was determined in duplicate by the MO, USA) containing 200 IU/ml penicillin (Hoechst, Darmstadt, same immunoradiometric assay as described above. The change Germany), 200 µg/ml streptomycin (Hoechst) and 2.5 µg/ml fungizone between pre-and postoperative CA125 concentrations was (Gibco, Basle, Switzerland).
calculated and log transformed. Statistical analyses were perExplants of uterine and abdominal peritoneum, and myometrium formed by Student's t and χ 2 tests. were cultured in RPMI 1640 (Merck, Darmstaadt, Germany) containing 10% FCS (fetal calf serum) (Animed, Basel, Switzerland),
Results
100 ng/ml streptomycine, 0.1 IU/ml penicillin and 2.5 ng/ml fungizone (referred to as complete RPMI hereafter). To mimic bacterial infec-
Tissue cultures
tion, complete RPMI was supplemented in some experiments by
In the uterine peritoneal explant cultures (n ϭ 12), we observed 100 µg/ml lipopolysaccharides (LPS; Sigma, Buchs, Switzerland). In CA125 concentrations varying between 83.9 Ϯ 135.1 and other experiments, ascitic fluid (30% v/v) was added to complete RPMI 627.8 Ϯ 367.9 IU/mg protein (mean Ϯ SD) according to the to mimic cancer. Finally, complete RPMI was also supplemented sometimes with cycloheximide (10 µg/ml, Sigma) to inhibit protein days of culture and the treatments. Irrespective of the culture synthesis.
conditions, CA125 concentrations gradually decreased with Media were collected on days 2, 5 and 8 and CA125 concentration the time of incubation. However, no viability test was done to determined in duplicate in the supernatants by an immunoradiometric exclude the possibility that this decrease was due to cell death. 
Discussion
We could not demonstrate in-vitro de-novo synthesis of CA125 under our experimental conditions since an inhibitor of protein synthesis such as cycloheximide did not change the concentrations of CA125 found in the incubation medium. Addition of cycloheximide has been shown to decrease significantly the concentrations of CA125 secreted in the medium by explants of decidua (Bischof et al., 1986) . Our results suggest that uterine and abdominal peritoneum, and myometrium are not a source of CA125 production. In the explant cultures we noticed that the CA125 concentrations decreased progressively with the time of incubation. This can be explained either by inhibition of de-novo production of the antigen in our culture however, that the interpretation of these data is somewhat difficult because the half-life of CA125 in vitro is unknown and the viability of the explants in culture could not be assessed.
Our observations seem to exclude the possibility that these tissues actively produce CA125 in vitro. Different inflammatory situations such as pelvic inflammatory disease, endometriosis (especially with adhesions), malignant pathologies with ascites and peritonitis are known to induce high circulating concentrations of CA125. In order to mimic cancer or an inflammation, peritoneal explant cultures were performed in medium supplemented with ascitic fluid or LPS, speculating that these two substances could stimulate potential CA125 production. Even under these conditions, we do not find a significant effect on results (Zeillemaker et al., 1994) . These last authors cultured mesothelial cells for 6 h and observed that the secretion of Table I . Of the 40 patients, seven (three men and four women) CA125 by cells grown in medium with LPS, IL-1β or TNFhad a preoperative CA125 concentration above 35 IU/ml and α was statistically higher than in unstimulated cells. However, were excluded from further analysis as discussed below. the kinetics of the two studies are different: we measured Table II shows the characteristics of the remaining patients CA125 after 2-8 days. This could perhaps explain the different with a preoperative CA125 Ͻ35 IU/ml. The groups are results. The difference in the culture medium and the use of comparable in age. The mean postoperative value of CA125 antibiotics certainly does not explain our negative results. in the group 'peritoneal surgery -men' was high (55.8 IU/ml Among the 40 patients included in the prospective study, Ϯ 63.2) with a high standard deviation. This is due to one seven had a preoperative CA125 Ͼ35 IU/ml associated with case of gastrojejunal anastomosis cancer with a postoperative malignant (pancreas, lymphoma, gastric and breast) and benign CA125 concentration of 167.11 IU/ml. The postoperative (uterine fibroid, thyroid) conditions. This underlines the lack CA125 values were not significantly different from the preoperof specificity of this marker for ovarian cancer. We excluded ative ones when considering the different groups (peritoneal these cases from further analysis in order to avoid a possible surgery or extraperitoneal surgery in men and/or women).
decrease in postoperative CA125 due to tumour removal, as Since the CA125 assay had an interassay coefficient of variation shown previously (Yedema et al., 1993) . Although our sample of 5.5%, we counted the number of patients who had a size was limited, we observed a significant difference in the postoperative CA125 concentration above the preoperative proportion of patients who had a postoperative increase of concentration ϩ5.5% and considered this increase as signific-CA125 when patients with abdominal and extra-abdominal ant. With this approach, 53.3% of patients had an increased surgery were compared. This suggests that, in vivo, the postoperative CA125 in the group of peritoneal surgery whereas peritoneum might contribute to circulating CA125 concentraonly 16.7% of the patients had such an increase in the group tions. These results confirm earlier studies (Talbot et al., 1989 ; of extraperitoneal surgery. This was statistically significant (χ 2 Yedema et al., 1993) in which a postoperative increase of test, P Ͻ 0.03). Analysing the female subgroup for the same CA125 after laparotomy was observed. In both studies, CA125 parameters, 33% of women with peritoneal surgery had a measurements were performed between 4 and 28 days after higher postoperative CA125 concentration against 0% in the surgery and the maximal rise in CA125 was detected 2-4 extraperitoneal group (P Ͻ 0.03). In the male group, we found 83.3 against 27.3% (P Ͻ 0.05).
weeks postoperatively (Talbot et al., 1989) . Our postoperative measurements were done after 48 h and an increased CA125 concentration. It must be admitted, however, that in the five cases with abdominal tumours, the contribution of tumour concentration, although not statistically significant, could already be observed. This marginal increase is taken as indirect manipulation to increased postoperative CA125 concentrations cannot be excluded. evidence of the peritoneal contribution to circulating CA125
